Skip to Content
Merck
  • Isosorbide-2-carbamate esters: potent and selective butyrylcholinesterase inhibitors.

Isosorbide-2-carbamate esters: potent and selective butyrylcholinesterase inhibitors.

Journal of medicinal chemistry (2008-09-27)
Ciaran G Carolan, Gerald P Dillon, Joanne M Gaynor, Sean Reidy, Sheila A Ryder, Denise Khan, Juan F Marquez, John F Gilmer
ABSTRACT

In this study, we report the SAR and characterization of two groups of isosorbide-based cholinesterase inhibitors. The first was based directly on the clinically used nitrate isosorbide mononitrate (ISMN) retention of the 5-nitrate group and introduction of a series of 2-carbamate functionalities. The compounds proved to be potent and selective inhibitors of human plasma butyrylcholinesterase ( huBuChE). In the second group, the nitrate ester was removed and replaced with a variety of alkyl and aryl esters. These generally exhibited nanomolar potency with high selectivity for BuChE over acetylcholinesterase (AChE). The most potent and selective compound was isosorbide-2-benzyl carbamate-5-benzoate with an IC 50 of 4.3 nM for BuChE and >50000 fold selectivity over human erythrocyte AChE. Inhibition with these compounds is time-dependent, competitive, and slowly reversible, indicating active site carbamylation.